V Bryan Lawlis - Net Worth and Insider Trading

V Bryan Lawlis Net Worth

The estimated net worth of V Bryan Lawlis is at least $2 Million dollars as of 2024-11-13. V Bryan Lawlis is the Director of Biomarin Pharmaceutical Inc and owns about 28,950 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $2 Million. V Bryan Lawlis is also the Director of Geron Corp and owns about 0 shares of Geron Corp (GERN) stock worth over $0. Details can be seen in V Bryan Lawlis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that V Bryan Lawlis has not made any transactions after 2023-05-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of V Bryan Lawlis

V Bryan Lawlis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, V Bryan Lawlis owns 7 companies in total, including Spyre Therapeutics Inc (SYRE) , Geron Corp (GERN) , and Biomarin Pharmaceutical Inc (BMRN) among others .

Click here to see the complete history of V Bryan Lawlis’s form 4 insider trades.

Insider Ownership Summary of V Bryan Lawlis

Ticker	Comapny	Transaction Date	Type of Owner
SYRE	Spyre Therapeutics Inc	2018-07-13	director
GERN	Geron Corp	2023-05-11	director
BMRN	Biomarin Pharmaceutical Inc	2023-04-03	director
		2016-05-24	director
		2018-09-26	director
		2013-08-07	director
		2006-03-07	director & President

V Bryan Lawlis Latest Holdings Summary

V Bryan Lawlis currently owns a total of 2 stocks. Among these stocks, V Bryan Lawlis owns 28,950 shares of Biomarin Pharmaceutical Inc (BMRN) as of April 3, 2023, with a value of $2 Million and a weighting of 100%. V Bryan Lawlis also owns 0 shares of Geron Corp (GERN) as of May 11, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of V Bryan Lawlis

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BMRN	Biomarin Pharmaceutical Inc	2023-04-03	28,950	66.12	1,914,174
GERN	Geron Corp	2023-05-11	0	3.97	0

Holding Weightings of V Bryan Lawlis

V Bryan Lawlis Form 4 Trading Tracker

According to the SEC Form 4 filings, V Bryan Lawlis has made a total of 6 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 8,500 shares on April 3, 2023, which brought V Bryan Lawlis around $825,265.

According to the SEC Form 4 filings, V Bryan Lawlis has made a total of 1 transactions in Geron Corp (GERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Geron Corp is the sale of 35,000 shares on May 11, 2023, which brought V Bryan Lawlis around $105,000.

Insider Trading History of V Bryan Lawlis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

V Bryan Lawlis Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

V Bryan Lawlis Ownership Network

Ownership Network List of V Bryan Lawlis

No Data

Ownership Network Relation of V Bryan Lawlis

V Bryan Lawlis Owned Company Details

What does Spyre Therapeutics Inc do?

Who are the key executives at Spyre Therapeutics Inc?

V Bryan Lawlis is the director of Spyre Therapeutics Inc. Other key executives at Spyre Therapeutics Inc include Chief Financial Officer Scott L Burrows , See Remarks Heidy King-jones , and director & 10 percent owner Fairmount Healthcare Co-invest L.p. .

Spyre Therapeutics Inc (SYRE) Insider Trades Summary

Over the past 18 months, V Bryan Lawlis made no insider transaction in Spyre Therapeutics Inc (SYRE). Other recent insider transactions involving Spyre Therapeutics Inc (SYRE) include a net sale of 7,000 shares made by Jeffrey W. Albers , and a net sale of 18,531 shares made by Scott L Burrows .

In summary, during the past 3 months, insiders sold 25,531 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 25,531 shares. During the past 18 months, 25,531 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,531 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spyre Therapeutics Inc Insider Transactions

No Available Data

What does Geron Corp do?

Who are the key executives at Geron Corp?

V Bryan Lawlis is the director of Geron Corp. Other key executives at Geron Corp include EVP & Technical Operations Andrew J Grethlein , EVP & Corp Strategy & CCO Anil Kapur , and EVP & Chief Medical Officer Faye Feller .

Geron Corp (GERN) Insider Trades Summary

Over the past 18 months, V Bryan Lawlis made no insider transaction in Geron Corp (GERN). Other recent insider transactions involving Geron Corp (GERN) include a net sale of 674,348 shares made by Andrew J Grethlein , a net sale of 600,000 shares made by John A Scarlett , and a net sale of 421,875 shares made by Anil Kapur .

In summary, during the past 3 months, insiders sold 0 shares of Geron Corp (GERN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,984,123 shares of Geron Corp (GERN) were sold and 13,186 shares were bought by its insiders, resulting in a net sale of 1,970,937 shares.

Geron Corp (GERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Geron Corp Insider Transactions

No Available Data

What does Biomarin Pharmaceutical Inc do?

Who are the key executives at Biomarin Pharmaceutical Inc?

V Bryan Lawlis is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include GVP & Chief Accounting Officer Erin Burkhart , EVP & Chief Financial Officer Brian Mueller , and VP & General Counsel George Eric Davis .

Biomarin Pharmaceutical Inc (BMRN) Insider Trades Summary

Over the past 18 months, V Bryan Lawlis made no insider transaction in Biomarin Pharmaceutical Inc (BMRN). Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 153,000 shares made by Jean Jacques Bienaime , a net sale of 92,066 shares made by George Eric Davis , and a net sale of 14,000 shares made by Jeffrey Robert Ajer .

In summary, during the past 3 months, insiders sold 0 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 319,767 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 319,767 shares.

Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biomarin Pharmaceutical Inc Insider Transactions

No Available Data

What does Coherus BioSciences Inc do?

Who are the key executives at Coherus BioSciences Inc?

V Bryan Lawlis is the director of Coherus BioSciences Inc. Other key executives at Coherus BioSciences Inc include director & President and CEO Dennis M Lanfear , Chief Financial Officer Mcdavid Stilwell , and See Remarks Bryan J Mcmichael .

Coherus BioSciences Inc (CHRS) Insider Trades Summary

Over the past 18 months, V Bryan Lawlis made no insider transaction in Coherus BioSciences Inc (CHRS). Other recent insider transactions involving Coherus BioSciences Inc (CHRS) include a net sale of 223,100 shares made by Dennis M Lanfear ,

In summary, during the past 3 months, insiders sold 0 shares of Coherus BioSciences Inc (CHRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 223,100 shares of Coherus BioSciences Inc (CHRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 223,100 shares.

Coherus BioSciences Inc (CHRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Coherus BioSciences Inc Insider Transactions

No Available Data

What does Sutro Biopharma Inc do?

Who are the key executives at Sutro Biopharma Inc?

V Bryan Lawlis is the director of Sutro Biopharma Inc. Other key executives at Sutro Biopharma Inc include Chief Port. Strat & Alnce Ofcr Nicki Vasquez , Chief Scientific Officer Hans-peter Gerber , and Chief Business Officer Brunilda Shtylla .

Sutro Biopharma Inc (STRO) Insider Trades Summary

Over the past 18 months, V Bryan Lawlis made no insider transaction in Sutro Biopharma Inc (STRO). Other recent insider transactions involving Sutro Biopharma Inc (STRO) include a net sale of 27,041 shares made by Brunilda Shtylla , and a net sale of 12,185 shares made by Nicki Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of Sutro Biopharma Inc (STRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,226 shares of Sutro Biopharma Inc (STRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,226 shares.

Sutro Biopharma Inc (STRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sutro Biopharma Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

V Bryan Lawlis is the director of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, V Bryan Lawlis made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

V Bryan Lawlis is the director & President of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

V Bryan Lawlis Mailing Address

Above is the net worth, insider trading, and ownership report for V Bryan Lawlis. Currently GuruFocus does not have mailing address information for V Bryan Lawlis.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.